This report was recently updated on July 20 2024 with the latest and most recent
market numbers
Global Viral Sepsis Diagnostics Market Size, Trends & Analysis - Forecasts to 2029 By Diagnostic Method (Molecular Diagnostics, Serological Testing, Point-of-Care Testing, and Others), By Virus Type (Influenza Virus, Respiratory Syncytial Virus (RSV), Herpes Simplex Virus (HSV), Human Immunodeficiency Virus (HIV), Hepatitis Viruses (HCV, HBV), Dengue Virus, and Others), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global viral sepsis diagnostics market is estimated to exhibit a CAGR of 9.4% from 2024 to 2029.
The primary factors propelling the market growth are the growing demand for viral infection diagnostics and the rising awareness of rapid sepsis detection solutions. The viral infection diagnostics surge is fueled by the need for advanced viral sepsis testing methods to identify and manage sepsis cases caused by viral pathogens accurately. Enhanced sepsis biomarker detection techniques are crucial for timely diagnosis, facilitating appropriate and swift treatment decisions. Innovative Viral sepsis screening tools are increasingly being developed and adopted, providing healthcare professionals with reliable means to detect sepsis early. Moreover, immunoassay-based sepsis tests are gaining traction due to their high specificity and sensitivity in identifying viral sepsis biomarkers. These advancements not only improve patient outcomes but also drive market growth as healthcare systems worldwide prioritize effective sepsis management. For instance, 12,150 instances of sepsis were reported in 2022 in Ireland, up 7.9% from 2021 (11,265), according to the National Sepsis Outcome Report 2022.
Advancements in molecular diagnostic assays and the expansion of point-of-care sepsis tests are expected to support the market growth. Integrating blood culture diagnostics at the point-of-care allows for quicker pathogen identification, thus expediting treatment. Moreover, the development of advanced sepsis diagnostic algorithms enhances the accuracy and efficiency of these tests, aiding in early and precise diagnosis. The identification of viral sepsis prognosis markers further refines the predictive capabilities of point-of-care diagnostics, enabling tailored treatment plans. Additionally, the incorporation of diagnostic imaging for sepsis at the point-of-care provides comprehensive insights into the patient's condition, supporting thorough and informed medical decisions.
The development of innovative sepsis diagnosis technologies and the rising incidence of septic shock diagnosis cases propel market growth. Advances in clinical microbiology testing are leading to more precise and rapid identification of pathogens, crucial for effective sepsis management. These innovations align with evolving sepsis diagnostic guidelines, ensuring healthcare practices stay current with the latest standards and recommendations for accurate diagnosis and treatment. Additionally, comprehensive sepsis diagnostic market analysis reveals a growing demand for advanced diagnostic tools that can quickly and accurately detect viral sepsis. The integration of cutting-edge technologies, such as molecular diagnostics and next-generation sepsis diagnostics, is transforming the landscape of sepsis diagnosis.
By providing quicker and more precise identification of sepsis-causing organisms, emerging sepsis diagnostic technologies, including next-generation sequencing (NGS) and polymerase chain reaction (PCR) tests, are creating opportunities in the market. Additionally, sepsis diagnostic technologies are incorporating machine learning and artificial intelligence to improve patient stratification, lessen false positives, and improve prediction and diagnostic accuracy.
However, viral sepsis diagnostic challenges such as the overlap of symptoms and the need for specific biomarkers and high cost of advanced diagnostic tools impede market growth.
The molecular diagnostics segment is expected to hold the largest share of the market over the forecast period. Compared to conventional procedures, molecular diagnostic testing can yield findings considerably more quickly. Proper antiviral medication's timely commencement is crucial in controlling sepsis and lowering death rates, and it is made possible by the prompt identification of the causal virus.
The point-of-care testing segment is expected to be the fastest-growing segment in the market from 2024 to 2029. Point-of-care testing is intended to be conveniently conducted in non-laboratory contexts, such as emergency rooms, critical care units, or outpatient clinics. Due to its ease of use and accessibility, patients can be tested, and decisions can be made quickly, which speeds up the process of starting the right therapy and enhances patient outcomes.
The influenza virus segment is expected to hold the largest share of the market over the forecast period. Influenza viruses, especially influenza A and B, are among the most prevalent viral pathogens linked to sepsis and respiratory diseases. Seasonal influenza epidemics happen every year and heavily impact global healthcare systems. The increasing incidence of influenza partly causes the increased need for diagnostic testing, particularly for this virus, driving market growth.
The dengue virus segment is anticipated to be the fastest-growing segment in the market from 2024 to 2029. Dengue virus infections can present a wide spectrum of clinical manifestations, ranging from mild febrile illness to severe and potentially life-threatening disease. Severe dengue cases may involve vascular leakage, plasma leakage, and systemic inflammation, which can progress rapidly to severe sepsis and septic shock.
North America is expected to be the largest region in the global market. Viral infections such as influenza, respiratory syncytial virus (RSV), herpes simplex virus (HSV), and others are common in North America and can cause sepsis. The frequency of these illnesses drives the need for effective viral sepsis diagnostics.
Asia Pacific is anticipated to witness rapid growth during the forecast period. The Asia Pacific region's economic growth has raised investments in healthcare technologies and spending on healthcare services. The need for cutting-edge diagnostic techniques, such as viral sepsis diagnostics, is rising as the region's healthcare institutions modernize and put a greater emphasis on improving patient outcomes.
Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMérieux SA, Cepheid (a subsidiary of Danaher Corporation), F. Hoffmann-La Roche Ltd, Hologic, Inc., Luminex Corporation, Quidel Corporation, Thermo Fisher Scientific Inc., and Becton, Dickinson and Company, among others, are some of the key players in the global viral sepsis diagnostics market.
Please note: This is not an exhaustive list of companies profiled in the report.
In February 2023, Immunexpress launched the SeptiCyte Rapid test in the United States. This test allows for hourly sepsis diagnosis in patients. The point-of-care test can improve outcomes and enable timely intervention by assisting doctors in identifying patients early.
In January 2023, the new IntelliSep sepsis diagnostic test was launched by Cytovale. The enhanced test is intended for sepsis patients admitted to emergency rooms.
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3 GLOBAL MARKET OUTLOOK
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY Diagnostic Method
4.1 Introduction
4.2 Viral Sepsis Diagnostics Market: Diagnostic Method Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Molecular Diagnostics
4.4.1 Molecular Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
4.5 Serological Testing
4.5.1 Serological Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.6 Point-of-Care Testing
4.6.1 Point-of-Care Testing Market Estimates and Forecast, 2021-2029 (USD Million)
4.7 Others
4.7.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
5 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY VIRUS TYPE
5.1 Introduction
5.2 Viral Sepsis Diagnostics Market: Virus Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Influenza Virus
5.4.1 Influenza Virus Market Estimates and Forecast, 2021-2029 (USD Million)
5.5 Respiratory Syncytial Virus (RSV)
5.5.1 Respiratory Syncytial Virus (RSV) Market Estimates and Forecast, 2021-2029 (USD Million)
5.6 Herpes Simplex Virus (HSV)
5.6.1 Herpes Simplex Virus (HSV) Market Estimates and Forecast, 2021-2029 (USD Million)
5.7 Human Immunodeficiency Virus (HIV)
5.7.1 Human Immunodeficiency Virus (HIV) Market Estimates and Forecast, 2021-2029 (USD Million)
5.8 Hepatitis Viruses (HCV, HBV)
5.8.1 Hepatitis Viruses (HCV, HBV) Market Estimates and Forecast, 2021-2029 (USD Million)
5.9 Dengue Virus
5.9.1 Dengue Virus Market Estimates and Forecast, 2021-2029 (USD Million)
5.10 Others
5.10.1 Others Market Estimates and Forecast, 2021-2029 (USD Million)
6 GLOBAL VIRAL SEPSIS DIAGNOSTICS MARKET, BY REGION
6.1 Introduction
6.2 North America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.1 By Diagnostic Method
6.2.2 By Virus Type
6.2.3 By Country
6.2.3.1 U.S. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.1.1 By Diagnostic Method
6.2.3.1.2 By Virus Type
6.2.3.2 Canada Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.2.1 By Diagnostic Method
6.2.3.2.2 By Virus Type
6.2.3.3 Mexico Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.2.3.3.1 By Diagnostic Method
6.2.3.3.2 By Virus Type
6.3 Europe Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.1 By Diagnostic Method
6.3.2 By Virus Type
6.3.3 By Country
6.3.3.1 Germany Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.1.1 By Diagnostic Method
6.3.3.1.2 By Virus Type
6.3.3.2 U.K. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.2.1 By Diagnostic Method
6.3.3.2.2 By Virus Type
6.3.3.3 France Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.3.1 By Diagnostic Method
6.3.3.3.2 By Virus Type
6.3.3.4 Italy Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.4.1 By Diagnostic Method
6.3.3.4.2 By Virus Type
6.3.3.5 Spain Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.5.1 By Diagnostic Method
6.3.3.5.2 By Virus Type
6.3.3.6 Netherlands Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Diagnostic Method
6.3.3.6.2 By Virus Type
6.3.3.7 Rest of Europe Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.3.3.6.1 By Diagnostic Method
6.3.3.6.2 By Virus Type
6.4 Asia Pacific Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.1 By Diagnostic Method
6.4.2 By Virus Type
6.4.3 By Country
6.4.3.1 China Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.1.1 By Diagnostic Method
6.4.3.1.2 By Virus Type
6.4.3.2 Japan Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.2.1 By Diagnostic Method
6.4.3.2.2 By Virus Type
6.4.3.3 India Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.3.1 By Diagnostic Method
6.4.3.3.2 By Virus Type
6.4.3.4 South Korea Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.4.1 By Diagnostic Method
6.4.3.4.2 By Virus Type
6.4.3.5 Singapore Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.5.1 By Diagnostic Method
6.4.3.5.2 By Virus Type
6.4.3.6 Malaysia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Diagnostic Method
6.4.3.6.2 By Virus Type
6.4.3.7 Thailand Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.6.1 By Diagnostic Method
6.4.3.6.2 By Virus Type
6.4.3.8 Indonesia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.7.1 By Diagnostic Method
6.4.3.7.2 By Virus Type
6.4.3.9 Vietnam Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.8.1 By Diagnostic Method
6.4.3.8.2 By Virus Type
6.4.3.10 Taiwan Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.10.1 By Diagnostic Method
6.4.3.10.2 By Virus Type
6.4.3.11 Rest of Asia Pacific Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.4.3.11.1 By Diagnostic Method
6.4.3.11.2 By Virus Type
6.5 Middle East and Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.1 By Diagnostic Method
6.5.2 By Virus Type
6.5.3 By Country
6.5.3.1 Saudi Arabia Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.1.1 By Diagnostic Method
6.5.3.1.2 By Virus Type
6.5.3.2 U.A.E. Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.2.1 By Diagnostic Method
6.5.3.2.2 By Virus Type
6.5.3.3 Israel Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.3.1 By Diagnostic Method
6.5.3.3.2 By Virus Type
6.5.3.4 South Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.4.1 By Diagnostic Method
6.5.3.4.2 By Virus Type
6.5.3.5 Rest of Middle East and Africa Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.5.3.5.1 By Diagnostic Method
6.5.3.5.2 By Virus Type
6.6 Central and South America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.1 By Diagnostic Method
6.6.2 By Virus Type
6.6.3 By Country
6.6.3.1 Brazil Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.1.1 By Diagnostic Method
6.6.3.1.2 By Virus Type
6.6.3.2 Argentina Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.2.1 By Diagnostic Method
6.6.3.2.2 By Virus Type
6.6.3.3 Chile Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Diagnostic Method
6.6.3.3.2 By Virus Type
6.6.3.3 Rest of Central and South America Viral Sepsis Diagnostics Market Estimates and Forecast, 2021-2029 (USD Million)
6.6.3.3.1 By Diagnostic Method
6.6.3.3.2 By Virus Type
7 COMPETITIVE LANDCAPE
7.1 Company Market Share Analysis
7.2 Four Quadrant Positioning Matrix
7.2.1 Market Leaders
7.2.2 Market Visionaries
7.2.3 Market Challengers
7.2.4 Niche Market Players
7.3 Vendor Landscape
7.3.1 North America
7.3.2 Europe
7.3.3 Asia Pacific
7.3.4 Rest of the World
7.4 Company Profiles
7.4.1 Abbott Laboratories
7.4.1.1 Business Description & Financial Analysis
7.4.1.2 SWOT Analysis
7.4.1.3 Products & Services Offered
7.4.1.4 Strategic Alliances between Business Partners
7.4.2 Bio-Rad Laboratories, Inc.
7.4.2.1 Business Description & Financial Analysis
7.4.2.2 SWOT Analysis
7.4.2.3 Products & Services Offered
7.4.2.4 Strategic Alliances between Business Partners
7.4.3 BioMérieux SA
7.4.3.1 Business Description & Financial Analysis
7.4.3.2 SWOT Analysis
7.4.3.3 Products & Services Offered
7.4.3.4 Strategic Alliances between Business Partners
7.4.4 Cepheid (a subsidiary of Danaher Corporation)
7.4.4.1 Business Description & Financial Analysis
7.4.4.2 SWOT Analysis
7.4.4.3 Products & Services Offered
7.4.4.4 Strategic Alliances between Business Partners
7.4.5 F. Hoffmann-La Roche Ltd
7.4.5.1 Business Description & Financial Analysis
7.4.5.2 SWOT Analysis
7.4.5.3 Products & Services Offered
7.4.5.4 Strategic Alliances between Business Partners
7.4.6 HOLOGIC, INC.
7.4.6.1 Business Description & Financial Analysis
7.4.6.2 SWOT Analysis
7.4.6.3 Products & Services Offered
7.4.6.4 Strategic Alliances between Business Partners
7.4.7 Luminex Corporation
7.4.7.1 Business Description & Financial Analysis
7.4.7.2 SWOT Analysis
7.4.7.3 Products & Services Offered
7.4.7.4 Strategic Alliances between Business Partners
7.4.8 Quidel Corporation
7.4.8.1 Business Description & Financial Analysis
7.4.8.2 SWOT Analysis
7.4.8.3 Products & Services Offered
7.4.8.4 Strategic Alliances between Business Partners
7.4.9 Thermo Fisher Scientific Inc.
7.4.9.1 Business Description & Financial Analysis
7.4.9.2 SWOT Analysis
7.4.9.3 Products & Services Offered
7.4.9.4 Strategic Alliances between Business Partners
7.4.10 Becton, Dickinson and Company
7.4.10.1 Business Description & Financial Analysis
7.4.10.2 SWOT Analysis
7.4.10.3 Products & Services Offered
7.4.10.4 Strategic Alliances between Business Partners
7.4.11 Other Companies
7.4.11.1 Business Description & Financial Analysis
7.4.11.2 SWOT Analysis
7.4.11.3 Products & Services Offered
7.4.11.4 Strategic Alliances between Business Partners
8 RESEARCH METHODOLOGY
8.1 Market Introduction
8.1.1 Market Definition
8.1.2 Market Scope & Segmentation
8.2 Information Procurement
8.2.1 Secondary Research
8.2.1.1 Purchased Databases
8.2.1.2 GMEs Internal Data Repository
8.2.1.3 Secondary Resources & Third Party Perspectives
8.2.1.4 Company Information Sources
8.2.2 Primary Research
8.2.2.1 Various Types of Respondents for Primary Interviews
8.2.2.2 Number of Interviews Conducted throughout the Research Process
8.2.2.3 Primary Stakeholders
8.2.2.4 Discussion Guide for Primary Participants
8.2.3 Expert Panels
8.2.3.1 Expert Panels Across 30+ Industry
8.2.4 Paid Local Experts
8.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
8.3 Market Estimation
8.3.1 Top-Down Approach
8.3.1.1 Macro-Economic Indicators Considered
8.3.1.2 Micro-Economic Indicators Considered
8.3.2 Bottom Up Approach
8.3.2.1 Company Share Analysis Approach
8.3.2.2 Estimation of Potential Product Sales
8.4 Data Triangulation
8.4.1 Data Collection
8.4.2 Time Series, Cross Sectional & Panel Data Analysis
8.4.3 Cluster Analysis
8.5 Analysis and Output
8.5.1 Inhouse AI Based Real Time Analytics Tool
8.5.2 Output From Desk & Primary Research
8.6 Research Assumptions & Limitations
8.6.1 Research Assumptions
8.6.2 Research Limitations
LIST OF TABLES
1 Global Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
2 Molecular Diagnostics Market, By Region, 2021-2029 (USD Mllion)
3 Serological Testing Market, By Region, 2021-2029 (USD Mllion)
4 Point-of-Care Testing Market, By Region, 2021-2029 (USD Mllion)
5 Others Market, By Region, 2021-2029 (USD Mllion)
6 Global Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
7 Influenza Virus Market, By Region, 2021-2029 (USD Mllion)
8 Respiratory Syncytial Virus (RSV) Market, By Region, 2021-2029 (USD Mllion)
9 Herpes Simplex Virus (HSV) Market, By Region, 2021-2029 (USD Mllion)
10 Human Immunodeficiency Virus (HIV) Market, By Region, 2021-2029 (USD Mllion)
11 Hepatitis Viruses (HCV, HBV) Market, By Region, 2021-2029 (USD Mllion)
12 Dengue Virus Market, By Region, 2021-2029 (USD Mllion)
13 Others Market, By Region, 2021-2029 (USD Mllion)
14 Regional Analysis, 2021-2029 (USD Mllion)
15 North America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
16 North America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
17 North America Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)
18 U.S. Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
19 U.S. Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
20 Canada Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
21 Canada Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
22 Mexico Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
23 Mexico Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
24 Europe Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
25 Europe Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
26 EUROPE Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)
27 Germany Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
28 Germany Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
29 U.K. Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
30 U.K. Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
31 France Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
32 France Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
33 Italy Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
34 Italy Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
35 Spain Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
36 Spain Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
37 Netherlands Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
38 Netherlands Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
39 Rest Of Europe Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
40 Rest Of Europe Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
41 Asia Pacific Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
42 Asia Pacific Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
43 ASIA PACIFIC Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)
44 China Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
45 China Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
46 Japan Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
47 Japan Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
48 India Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
49 India Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
50 South Korea Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
51 South Korea Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
52 Singapore Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
53 Singapore Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
54 Thailand Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
55 Thailand Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
56 Malaysia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
57 Malaysia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
58 Indonesia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
59 Indonesia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
60 Vietnam Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
61 Vietnam Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
62 Taiwan Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
63 Taiwan Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
64 Rest of APAC Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
65 Rest of APAC Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
66 Middle East and Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
67 Middle East and Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
68 MIDDLE EAST & AFRICA Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)
69 Saudi Arabia Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
70 Saudi Arabia Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
71 UAE Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
72 UAE Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
73 Israel Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
74 Israel Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
75 South Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
76 South Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
77 Rest Of Middle East and Africa Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
78 Rest Of Middle East and Africa Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
79 Central and South America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
80 Central and South America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
81 CENTRAL AND SOUTH AMERICA Viral Sepsis Diagnostics Market, By COUNTRY, 2021-2029 (USD Mllion)
82 Brazil Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
83 Brazil Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
84 Chile Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
85 Chile Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
86 Argentina Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
87 Argentina Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
88 Rest Of Central and South America Viral Sepsis Diagnostics Market, By Diagnostic Method, 2021-2029 (USD Mllion)
89 Rest Of Central and South America Viral Sepsis Diagnostics Market, By Virus Type, 2021-2029 (USD Mllion)
90 Abbott Laboratories: Products & Services Offering
91 Bio-Rad Laboratories, Inc.: Products & Services Offering
92 BioMérieux SA: Products & Services Offering
93 Cepheid (a subsidiary of Danaher Corporation): Products & Services Offering
94 F. Hoffmann-La Roche Ltd: Products & Services Offering
95 HOLOGIC, INC.: Products & Services Offering
96 Luminex Corporation: Products & Services Offering
97 Quidel Corporation: Products & Services Offering
98 Thermo Fisher Scientific Inc., Inc: Products & Services Offering
99 Becton, Dickinson and Company: Products & Services Offering
100 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Viral Sepsis Diagnostics Market Overview
2 Global Viral Sepsis Diagnostics Market Value From 2021-2029 (USD Mllion)
3 Global Viral Sepsis Diagnostics Market Share, By Diagnostic Method (2023)
4 Global Viral Sepsis Diagnostics Market Share, By Virus Type (2023)
5 Global Viral Sepsis Diagnostics Market, By Region (Asia Pacific Market)
6 Technological Trends In Global Viral Sepsis Diagnostics Market
7 Four Quadrant Competitor Positioning Matrix
8 Impact Of Macro & Micro Indicators On The Market
9 Impact Of Key Drivers On The Global Viral Sepsis Diagnostics Market
10 Impact Of Challenges On The Global Viral Sepsis Diagnostics Market
11 Porter’s Five Forces Analysis
12 Global Viral Sepsis Diagnostics Market: By Diagnostic Method Scope Key Takeaways
13 Global Viral Sepsis Diagnostics Market, By Diagnostic Method Segment: Revenue Growth Analysis
14 Molecular Diagnostics Market, By Region, 2021-2029 (USD Mllion)
15 Serological Testing Market, By Region, 2021-2029 (USD Mllion)
16 Point-of-Care Testing Market, By Region, 2021-2029 (USD Mllion)
17 Others Market, By Region, 2021-2029 (USD Mllion)
18 Global Viral Sepsis Diagnostics Market: By Virus Type Scope Key Takeaways
19 Global Viral Sepsis Diagnostics Market, By Virus Type Segment: Revenue Growth Analysis
20 Influenza Virus Market, By Region, 2021-2029 (USD Mllion)
21 Respiratory Syncytial Virus (RSV) Market, By Region, 2021-2029 (USD Mllion)
22 Herpes Simplex Virus (HSV) Market, By Region, 2021-2029 (USD Mllion)
23 Human Immunodeficiency Virus (HIV) Market, By Region, 2021-2029 (USD Mllion)
24 Hepatitis Viruses (HCV, HBV) Market, By Region, 2021-2029 (USD Mllion)
25 Dengue Virus Market, By Region, 2021-2029 (USD Mllion)
26 Others Market, By Region, 2021-2029 (USD Mllion)
27 Regional Segment: Revenue Growth Analysis
28 Global Viral Sepsis Diagnostics Market: Regional Analysis
29 North America Viral Sepsis Diagnostics Market Overview
30 North America Viral Sepsis Diagnostics Market, By Diagnostic Method
31 North America Viral Sepsis Diagnostics Market, By Virus Type
32 North America Viral Sepsis Diagnostics Market, By Country
33 U.S. Viral Sepsis Diagnostics Market, By Diagnostic Method
34 U.S. Viral Sepsis Diagnostics Market, By Virus Type
35 Canada Viral Sepsis Diagnostics Market, By Diagnostic Method
36 Canada Viral Sepsis Diagnostics Market, By Virus Type
37 Mexico Viral Sepsis Diagnostics Market, By Diagnostic Method
38 Mexico Viral Sepsis Diagnostics Market, By Virus Type
39 Four Quadrant Positioning Matrix
40 Company Market Share Analysis
41 Abbott Laboratories: Company Snapshot
42 Abbott Laboratories: SWOT Analysis
43 Abbott Laboratories: Geographic Presence
44 Bio-Rad Laboratories, Inc.: Company Snapshot
45 Bio-Rad Laboratories, Inc.: SWOT Analysis
46 Bio-Rad Laboratories, Inc.: Geographic Presence
47 BioMérieux SA: Company Snapshot
48 BioMérieux SA: SWOT Analysis
49 BioMérieux SA: Geographic Presence
50 Cepheid (a subsidiary of Danaher Corporation): Company Snapshot
51 Cepheid (a subsidiary of Danaher Corporation): Swot Analysis
52 Cepheid (a subsidiary of Danaher Corporation): Geographic Presence
53 F. Hoffmann-La Roche Ltd: Company Snapshot
54 F. Hoffmann-La Roche Ltd: SWOT Analysis
55 F. Hoffmann-La Roche Ltd: Geographic Presence
56 HOLOGIC, INC.: Company Snapshot
57 HOLOGIC, INC.: SWOT Analysis
58 HOLOGIC, INC.: Geographic Presence
59 Luminex Corporation : Company Snapshot
60 Luminex Corporation : SWOT Analysis
61 Luminex Corporation : Geographic Presence
62 Quidel Corporation: Company Snapshot
63 Quidel Corporation: SWOT Analysis
64 Quidel Corporation: Geographic Presence
65 Thermo Fisher Scientific Inc., Inc.: Company Snapshot
66 Thermo Fisher Scientific Inc., Inc.: SWOT Analysis
67 Thermo Fisher Scientific Inc., Inc.: Geographic Presence
68 Becton, Dickinson and Company: Company Snapshot
69 Becton, Dickinson and Company: SWOT Analysis
70 Becton, Dickinson and Company: Geographic Presence
71 Other Companies: Company Snapshot
72 Other Companies: SWOT Analysis
73 Other Companies: Geographic Presence
The Global Viral Sepsis Diagnostics Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Viral Sepsis Diagnostics Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
